Clinical Trial

Analysis of the Reliability and Validity of Laser Speckle Contrast Imaging

Study acronym: LSCI
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 22, 2026 (before its estimated May 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is designed to validate laser speckle contrast imaging (LSCI) as a non-invasive method for measuring superficial gingival blood perfusion. Accurate assessment of vascularization is essential for understanding periodontal and peri-implant wound healing, yet current clinical methods are limited by subjective interpretation and low reproducibility. Repeated LSCI measurements will be performed in healthy gingival tissues and in tissues undergoing different mucogingival healing patterns, including primary and secondary intention healing. The study will also evaluate factors that may influence perfusion readings, such as angulation, retractors, mirror use, temperature, and heart rate. The primary objective is to determine the reproducibility of LSCI measurements and to support its use as a reliable tool for monitoring oral soft-tissue vascularization and healing.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-07.
Trial Details
NCT Number NCT07527351
Lead Sponsor Universidad Complutense de Madrid
Conditions Gingival Vascularization, Oral Soft Tissue Wound Healing, Laser Speckle Contrast Imaging, Periodontal Wound Healing
Enrollment 24 participants
Start Date 2026-04-13
Primary Completion 2026-05-20 (estimated)
Study Completion 2026-05-20 (estimated)
Updated on ClinicalTrials.gov 2026-04-22